- Gilman KE, Matiatos AP, Cracchiolo MJ, Moon AG, Davini DW, Simpson RJ, Katsanis E. Multiagent Intratumoral Immunotherapy Can Be Effective in A20 Lymphoma Clearance and Generation of Systemic T Cell Immunity. Cancers (Basel). 2023 Mar 24;15(7):1951. doi: 10.3390/cancers15071951. PMID: 37046612 Free PMC article.
- Molina MS, Hoffman EA, Stokes J, Kummet N, Simpson RJ, Katsanis E. Murine precursor to type 1 conventional dendritic cells induce tumor cytotoxicity and activation of the PD-1/PD-L1 pathway. Plos One 2022 Aug 18;17(8):e0273075. PMID: 35980974 PMCID: PMC9387840.
- Baker FL, Bigley AB, Agha NH, Pedlar CR, O'Connor DP, Bond RA, Bollard CM, Katsanis E, Simpson RJ. Systemic β-Adrenergic Receptor Activation Augments the ex vivo Expansion and Anti-Tumor Activity of Vγ9Vδ2 T-Cells. Front Immunol. 2019;10:3082. doi: 10.3389/fimmu.2019.03082. eCollection 2019. PubMed PMID: 32038628; PubMed Central PMCID: PMC6993603.
- Bigley AB, Baker FL, Simpson RJ. Cytomegalovirus: an unlikely ally in the fight against blood cancers?. Clin Exp Immunol. 2018 Sep;193(3):265-274. doi: 10.1111/cei.13152. Review. PubMed PMID: 29737525; PubMed Central PMCID: PMC6150251.
- Bigley AB, Rezvani K, Shah N, Sekine T, Balneger N, Pistillo M, Agha N, Kunz H, O'Connor DP, Bollard CM, Simpson RJ. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans. Clin Exp Immunol. 2016 Aug;185(2):239-51. doi: 10.1111/cei.12785. PubMed PMID: 26940026; PubMed Central PMCID: PMC4955006.
- Graner MW, Lillehei KO, Katsanis E. Endoplasmic reticulum chaperones and their roles in the immunogenicity of cancer vaccines. Front Oncol. 2015 Jan 6;4:379. doi: 10.3389/fonc.2014.00379. PMID: 25610811; PMCID: PMC4285071.
- Centuori SM, Trad M, LaCasse CJ, Alizadeh D, Larmonier CB, Hanke NT, Kartchner J, Janikashvili N, Bonnotte B, Larmonier N, Katsanis E. Myeloid- derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cells. J Leukoc Biol. 2012 Nov;92(5):987-97. doi: 10.1189/jlb.0911465. Epub 2012 Aug 13. PMID: 22891289; PMCID: PMC3476240.
- Larmonier N, Bonnotte B, Katsanis E. Cytotoxic and antigen presenting functions of T helper-1-activated dendritic cells. Oncoimmunology. 2012 Jul 1;1(4):566-568. doi: 10.4161/onci.19370. PMID: 22754789; PMCID: PMC3382885.
- Janikashvili N, Larmonier N, Katsanis E. Personalized dendritic cell-based tumor immunotherapy. Immunotherapy. 2010 Jan;2(1):57-68. doi: 10.2217/imt.09.78. PMID: 20161666; PMCID: PMC2819192.
- Cantrell J, Larmonier C, Janikashvili N, Bustamante S, Fraszczak J, Herrell A, Lundeen T, J LaCasse C, Situ E, Larmonier N, Katsanis E. Signaling pathways induced by a tumor-derived vaccine in antigen presenting cells. Immunobiology. 2010 Jul;215(7):535-44. doi: 10.1016/j.imbio.2009.09.006. Epub 2009 Oct 31. PMID: 19880213; PMCID: PMC2881173.
- Larmonier N, Fraszczak J, Lakomy D, Bonnotte B, Katsanis E. Killer dendritic cells and their potential for cancer immunotherapy. Cancer Immunol Immunother. 2010 Jan;59(1):1-11. doi: 10.1007/s00262-009-0736-1. Epub 2009 Jul 18. PMID: 19618185.
- Larmonier N, Janikashvili N, LaCasse CJ, Larmonier CB, Cantrell J, Situ E, Lundeen T, Bonnotte B, Katsanis E. Imatinib mesylate inhibits CD4+ CD25+ regulatory T cell activity and enhances active immunotherapy against BCR-ABL- tumors. J Immunol. 2008 Nov 15;181(10):6955-63. doi: 10.4049/jimmunol.181.10.6955. PMID: 18981115; PMCID: PMC2579962.
- Larmonier N, Cantrell J, Lacasse C, Li G, Janikashvili N, Situ E, Sepassi M, Andreansky S, Katsanis E. Chaperone-rich tumor cell lysate-mediated activation of antigen-presenting cells resists regulatory T cell suppression. J Leukoc Biol. 2008 Apr;83(4):1049-59. doi: 10.1189/jlb.0907635. Epub 2008 Jan 3. PMID: 18174364.
- Li G, Zeng Y, Chen X, Larmonier N, Sepassi M, Graner MW, Andreansky S, Brewer MA, Katsanis E. Human ovarian tumour-derived chaperone-rich cell lysate (CRCL) elicits T cell responses in vitro. Clin Exp Immunol. 2007 Apr;148(1):136-45. doi: 10.1111/j.1365-2249.2007.03323.x. PMID: 17349014; PMCID: PMC1868858.
- Zeng Y, Chen X, Larmonier N, Larmonier C, Li G, Sepassi M, Marron M, Andreansky S, Katsanis E. Natural killer cells play a key role in the antitumor immunity generated by chaperone-rich cell lysate vaccination. Int J Cancer. 2006 Dec 1;119(11):2624-31. doi: 10.1002/ijc.22150. PMID: 16989012.
- Larmonier N, Marron M, Zeng Y, Cantrell J, Romanoski A, Sepassi M, Thompson S, Chen X, Andreansky S, Katsanis E. Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10. Cancer Immunol Immunother. 2007 Jan;56(1):48-59. doi: 10.1007/s00262-006-0160-8. Epub 2006 Apr 13. PMID: 16612596.
- Zeng Y, Graner MW, Thompson S, Marron M, Katsanis E. Induction of BCR-ABL- specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells. Blood. 2005 Mar 1;105(5):2016-22. doi: 10.1182/blood-2004-05-1915. Epub 2004 Sep 16. PMID: 15374884; PMCID: PMC1227556.
- Zeng Y, Graner MW, Feng H, Li G, Katsanis E. Imatinib mesylate effectively combines with chaperone-rich cell lysate-loaded dendritic cells to treat bcr- abl+ murine leukemia. Int J Cancer. 2004 Jun 10;110(2):251-9. doi: 10.1002/ijc.20115. PMID: 15069690.
- Graner MW, Zeng Y, Feng H, Katsanis E. Tumor-derived chaperone-rich cell lysates are effective therapeutic vaccines against a variety of cancers. Cancer Immunol Immunother. 2003 Apr;52(4):226-34. doi: 10.1007/s00262-002-0359-2. Epub 2003 Feb 18. PMID: 12669247.
- Zeng Y, Feng H, Graner MW, Katsanis E. Tumor-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunity. Blood. 2003 Jun 1;101(11):4485-91. doi: 10.1182/blood-2002-10-3108. Epub 2003 Feb 6. PMID: 12576309.
- Feng H, Zeng Y, Graner MW, Likhacheva A, Katsanis E. Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity. Blood. 2003 Jan 1;101(1):245-52. doi: 10.1182/blood-2002-05-1580. Epub 2002 Aug 22. PMID: 12393411.
- Feng H, Zeng Y, Graner MW, Katsanis E. Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells. Blood. 2002 Dec 1;100(12):4108-15. doi: 10.1182/blood-2002-05-1389. Epub 2002 Jul 25. PMID: 12393401.
- Feng H, Zeng Y, Whitesell L, Katsanis E. Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity. Blood. 2001 Jun 1;97(11):3505-12. doi: 10.1182/blood.v97.11.3505. PMID: 11369644.
- He L, Feng H, Raymond A, Kreeger M, Zeng Y, Graner M, Whitesell L, Katsanis E. Dendritic-cell-peptide immunization provides immunoprotection against bcr- abl-positive leukemia in mice. Cancer Immunol Immunother. 2001 Mar;50(1):31-40. doi: 10.1007/pl00006680. PMID: 11315508.